Its downstream molecule NF-κB is often phosphorylated at serine sites and MAPKs at threonine and tyrosine sites to perform transcription regulation in cancer (Dhillon et al. 2007; Motolani et al. 2020). The gene discussed is NFKB1; the disease is cancer.